 |
|
|
| |
NGM282 Improves Fibrosis and NASH-Related Histology in
12 Weeks in Patients With Biopsy-Confirmed NASH, Which is Preceded By Significant Decreases in Hepatic Steatosis, Liver Transaminases and Fibrosis Markers at 6 Weeks
|
| |
| |
Reported by Jules Levin
EASL 2018 April 14 Paris France
Oral presentation
Stephen A. Harrison, Stephen J. Rossi, Mustafa R. Bashir,
Cynthia D. Guy, Rajarshi Banerjee, Mark J. Jaros, Sandra Owers,
Bryan A. Baxter, Lei Ling, Alex M. DePaoli
|
| |
|
|
|
|
|
